Ad
EGRX - Eagle Pharmaceuticals Stock Trading
Eagle Pharmaceuticals Inc. Company Name:
EGRX Stock Symbol:
NASDAQ Market:
Eagle Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Image source: The Motley Fool. Eagle Pharmaceuticals (NASDAQ: EGRX) Q2 2022 Earnings Call Aug 09, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Eagle Pharmaceuticals (EGRX) Q2 2022 Earnings Call Transcript
-
• Q2 2022 net loss was $(0.74) per basic and diluted share and adjusted non-GAAP net income was $1.58 per basic and $1.56 per diluted share • Total revenue for Q2 2022 was $74.1 million, compared to $48.1 million in Q2 2021, primarily reflecting product sales of ...
-
-- ENA-001 is currently in development for: post-operative respiratory depression, community drug overdose, and Apnea of Prematurity -- -- Approval for post-operative respiratory depression expected in 2026 and community drug overdose thereafter -- -- ENA-001 works peripherally by...